OBJECTIVE: The Fort Campbell Cohort study was designed to assess predeployment biological and behavioral markers and build predictive models to identify risk and resilience for posttraumatic stress disorder (PTSD) following deployment. This article addresses neurocognitive functioning variables as potential prospective predictors. METHOD: In a sample of 403 soldiers, we examined whether PTSD symptom severity (using the PTSD Checklist) as well as posttraumatic stress trajectories could be prospectively predicted by measures of executive functioning (using two web-based tasks from WebNeuro) assessed predeployment. RESULTS: Controlling for age, gender, education, prior number of deployments, childhood trauma exposure, and PTSD symptom severity at Phase 1, linear regression models revealed that predeployment sustained attention and inhibitory control performance were significantly associated with postdeployment PTSD symptom severity. We also identified two posttraumatic stress trajectories utilizing latent growth mixture models. The "resilient" group consisted of 90.9% of the soldiers who exhibited stable low levels of PTSD symptoms from pre- to postdeployment. The "increasing" group consisted of 9.1% of the soldiers, who exhibited an increase in PTSD symptoms following deployment, crossing a threshold for diagnosis based on PTSD Checklist scores. Logistic regression models predicting trajectory revealed a similar pattern of findings as the linear regression models, in which predeployment sustained attention (95% CI of odds ratio: 1.0109, 1.0558) and inhibitory control (95% CI: 1.0011, 1.0074) performance were significantly associated with postdeployment PTSD trajectory. CONCLUSIONS: These findings have clinical implications for understanding the pathogenesis of PTSD and building preventative programs for military personnel. (PsycINFO Database Record (c) 2020 APA, all rights reserved).
OBJECTIVE: The Fort Campbell Cohort study was designed to assess predeployment biological and behavioral markers and build predictive models to identify risk and resilience for posttraumatic stress disorder (PTSD) following deployment. This article addresses neurocognitive functioning variables as potential prospective predictors. METHOD: In a sample of 403 soldiers, we examined whether PTSD symptom severity (using the PTSD Checklist) as well as posttraumatic stress trajectories could be prospectively predicted by measures of executive functioning (using two web-based tasks from WebNeuro) assessed predeployment. RESULTS: Controlling for age, gender, education, prior number of deployments, childhood trauma exposure, and PTSD symptom severity at Phase 1, linear regression models revealed that predeployment sustained attention and inhibitory control performance were significantly associated with postdeployment PTSD symptom severity. We also identified two posttraumatic stress trajectories utilizing latent growth mixture models. The "resilient" group consisted of 90.9% of the soldiers who exhibited stable low levels of PTSD symptoms from pre- to postdeployment. The "increasing" group consisted of 9.1% of the soldiers, who exhibited an increase in PTSD symptoms following deployment, crossing a threshold for diagnosis based on PTSD Checklist scores. Logistic regression models predicting trajectory revealed a similar pattern of findings as the linear regression models, in which predeployment sustained attention (95% CI of odds ratio: 1.0109, 1.0558) and inhibitory control (95% CI: 1.0011, 1.0074) performance were significantly associated with postdeployment PTSD trajectory. CONCLUSIONS: These findings have clinical implications for understanding the pathogenesis of PTSD and building preventative programs for military personnel. (PsycINFO Database Record (c) 2020 APA, all rights reserved).
Authors: E Kate Webb; Carissa N Weis; Ashley A Huggins; Elizabeth A Parisi; Kenneth P Bennett; Tara Miskovich; Jessica Krukowski; Terri A deRoon-Cassini; Christine L Larson Journal: Health Place Date: 2020-12-13 Impact factor: 4.931
Authors: Carole E Siegel; Eugene M Laska; Ziqiang Lin; Mu Xu; Duna Abu-Amara; Michelle K Jeffers; Meng Qian; Nicholas Milton; Janine D Flory; Rasha Hammamieh; Bernie J Daigle; Aarti Gautam; Kelsey R Dean; Victor I Reus; Owen M Wolkowitz; Synthia H Mellon; Kerry J Ressler; Rachel Yehuda; Kai Wang; Leroy Hood; Francis J Doyle; Marti Jett; Charles R Marmar Journal: Transl Psychiatry Date: 2021-04-20 Impact factor: 6.222
Authors: Audreyana Jagger-Rickels; David Rothlein; Anna Stumps; Travis Clark Evans; John Bernstein; William Milberg; Regina McGlinchey; Joseph DeGutis; Michael Esterman Journal: Transl Psychiatry Date: 2022-06-27 Impact factor: 7.989
Authors: Liliana G Ciobanu; Lazar Stankov; K Oliver Schubert; Azmeraw T Amare; M Catharine Jawahar; Ellie Lawrence-Wood; Natalie T Mills; Matthew Knight; Scott R Clark; Eugene Aidman Journal: PLoS One Date: 2022-10-17 Impact factor: 3.752